AzTrials
AzTrials

A Stabilized Definitive Prosthesis (Procedure 1)NIRSNCT02551484

Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Healing After Amputation of the Leg

A study testing Measurements using NIRS, TCPO2 measurements and 2-minute walk test in people with A Stabilized Definitive Prosthesis (Procedure 1) and Definitive Prosthesis With a Contact Socket (Procedure 1), run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

50 patients will be included for each of the 2 procedures: For procedure 1: Patients will be selected during multidisciplinary consultations for amputees who are stabilized with their definitive prosthesis and have returned to their usual place of residence. Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
Measurements using NIRS, TCPO2 measurements and 2-minute walk test
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteFrance
Study dates
15 Jan 2013to 16 Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All groups:
  • Patients who have agreed to take part in the study
  • Patients with National Health Insurance cover,
  • Patients (men or women aged between 18 and 85 years, presenting unilateral transtibial amputation for PAD.
  • Able to understand simple instructions
  • Procedure 1:
Show all 11Show fewer
  • Stabilized patients with their definitive prosthesis, with no modification of the prosthesis in the previous 3 months and at least 6 months after the amputation.
  • Definitive prosthesis with a contact socket.
  • Patients able to do a 2-minute walk test.
  • Procedure 2:
  • Patients in the initial phase of post-amputation (temporary prosthesis, rehabilitation) following unilateral transtibial amputation.

Who cannot join

  • Patients without national health insurance cover.
  • Patients under guardianship.
  • Patients with associated chronic motor deficiency, of a neurological origin (examples: sequelae of stroke, balance and coordination disorders), or osteo-articular disease (examples: knee or hip osteoarthritis), given their secondary functional impact, making it impossible for amputees to walk with a prosthesis.
  • Severe medical disorder that significantly impairs functional abilities (severe heart failure, respiratory failure, non-stabilized metabolic disorders, such as progressive kidney failure) and diseases with an impact on short or medium-term survival (progressive neoplastic disease, non-stabilized systemic disease).
  • Complications, other than microcirculatory, with the stump, able to affect the use of a contact socket: hematoma, formation of cysts, fluid build-up, calcifications of soft tissues, bone spur, infection (skin, abscess), neurinoma, deterioration of the knee joint of the amputated limb, angle of the tibial cut leading to specifically painful osteo-cutaneous impingement, venous thrombosis, abnormal shape of the stump making it unsuitable for a socket (flexum of the knee, "pear shaped" stumps or stumps with severe invaginations )…
  • Local skin disorders in the measurement zone (summit of the antero-external area) of the stump compromising the quality of the signals picked up by the electrode (NIRS and TcPO2) : severe edema, hyperkeratosis, ulceration, inflammatory and infectious phenomena.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de DIJON

    Dijon, 21079

Other trials in France

About this study

Official title: Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Microcirculation Following Trans-tibial Amputation for Peripheral Artery Disease

50 patients will be included for each of the 2 procedures:

  • For procedure 1: Patients will be selected during multidisciplinary consultations for amputees who are stabilized with their definitive prosthesis and have returned to their usual place of residence. The aim of this procedure is to show the validity and reproducibility of measurements of tissue oxygenation using NIRS (TcPO2 being the reference measurement), to determine the way in which NIRS measurements are more precise (i.e. in terms of validity and reproductibility) (values at rest with the patient lying perfectly flat or with the amputated limb raised 30°). These patients will require a single visit which will include measurements by NIRS and TCPO2, a walk test and the completion of 2 questionnaires (visual scale).
  • For procedure 2: The patients will be included in the initial phase of postamputation rehabilitation, during the period of in-hospital rehabilitation. The main problems of healing and tolerance to the temporary prosthesis arise during this phase. The specific objectives will be: To show that measurement by NIRS predicts the quality of healing in trans-tibial amputees; to show that the zone of uncertainty concerning the predictive values for the viability of the stump is smaller with NIRS than with TcPO2 (better discrimination). NIRS and TCPO2 measurements as well as the evaluation of stump healing will be done 15, 30 and 45 days after the amputation.
Being tested
Measurements using NIRS, TCPO2 measurements, 2-minute walk test

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Measurements using NIRSDevice

  • TCPO2 measurementsDevice

  • 2-minute walk testOther

Study groups in NCT02551484
Study groupRoleWhat they receive
Procedure 1ExperimentalMeasures with 60 minutes interval during the consultation of equipment, functional testing, receuil pain.
Receives: Device: Measurements using NIRS; Device: TCPO2 measurements; Other: 2-minute walk test
Procedure 2ExperimentalMeasuring J15, J30 J 45 and after the different settings functional amputation, pain and tissue oxygenation.
Receives: Device: Measurements using NIRS; Device: TCPO2 measurements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. For procedure 1: the intra-class correlation coefficient between two successive NIRS measurements.

    Measured: Baseline

  2. For procedure 1: the Cronbach alpha coefficient between the NIRS and TcPO2 measurements (the latter being the gold standard).

    Measured: Baseline

  3. For procedure 2: NIRS values at the first consultation and the time to complete healing.

    Measured: Up to 60 days

  4. Procedure 2: NIRS values measured at different sessions and the associated healing evaluation.

    Measured: 45 days after the amputation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2015 (estimated)
  2. Study start15 Jan 2013
  3. Primary completion16 Nov 2018
  4. Study completion16 Nov 2018

Why it stopped: The patient population presenting in the department has evolved and no longer allows for the recruitment of the necessary number of patients.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02551484
Sponsor's protocol ID
CASILLAS Fd. Avenir 2012
Acronym
NIRS
Status last verified
Feb 2026
First submitted
20 Aug 2015
Last updated
9 Feb 2026
Results posted
No

Publications

  • Laroche D, Barnay JL, Tourlonias B, Orta C, Obert C, Casillas JM. Microcirculatory Assessment of Arterial Below-Knee Stumps: Near-Infrared Spectroscopy Versus Transcutaneous Oxygen Tension-A Preliminary Study in Prosthesis Users. Arch Phys Med Rehabil. 2017 Jun;98(6):1187-1194. doi: 10.1016/j.apmr.2016.12.001. Epub 2016 Dec 31.

    PubMed 28049004

Questions about this trial

What is this clinical trial studying?

A study testing Measurements using NIRS, TCPO2 measurements and 2-minute walk test in people with A Stabilized Definitive Prosthesis (Procedure 1) and Definitive Prosthesis With a Contact Socket (Procedure 1), run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 9 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: The patient population presenting in the department has evolved and no longer allows for the recruitment of the necessary number of patients.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

For procedure 1: the intra-class correlation coefficient between two successive NIRS measurements. (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02551484, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in